Budesonide/Formoterol Anti-Inflammatory Reliever and Maintenance or Fluticasone Propionate/Salmeterol Plus as-Needed, Short-Acting β2 Agonist: Real-World Effectiveness in patients Without Optimally Controlled asthma (REACT) Study [Corrigendum]
Keyword(s):
Keyword(s):
2005 ◽
Vol 59
(2)
◽
pp. 156-162
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):